FDA Approves Two Insulins

The Food and Drug Administration (FDA) surprisingly approved insulin degludec injection (Tresiba) and insulin degludec/insulin aspart injection (Ryzodeg) 70/30. Pharmacist and CDE Sam Grossman discusses some of the clinical trial findings for the medicines and offers some clinical prescribing guidance.